LigoCyte Pharmaceuticals, Inc.: Clinical Trials

2 trials sponsored by LigoCyte Pharmaceuticals, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow LigoCyte Pharmaceuticals, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
Norovirus challenge pool (GII.4, CIN-1) - Norovirus Infections
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati602011-08-012014-05-07
Phase 1 Norwalk Vaccine Study
Adjuvant/Excipients, placebo, Norwalk VLP Vaccine - Norovirus
Phase 1CompletedLigoCyte Pharmaceuticals, Inc.612008-11-012015-05-06

Conditions studied

Caliciviridae Infections (1)

Interventions

Adjuvants, Pharmaceutic (1)  ·  Excipients (1)

Countries

United States (2)

Top investigators

John J Treanor, MD (1)

Results publications

PMID 20979455